Skip to main content
OpenTrials

Clinical trial condition

Biochemically Recurrent Prostate Cancer

Explore clinical trials studying Biochemically Recurrent Prostate Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Biochemically Recurrent Prostate Cancer trial results

Completed

A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide

NCT05526248

Conditions
Biochemically Recurrent Prostate Cancer
Locations
  • Unio Specialty Care - Urology - Sherman Oaks Sherman Oaks, California, United States
  • Mass General Cancer Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center - Oncology Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York - Main Campus New York, United States
View Trial Details
Active, Not Recruiting

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

NCT05794906

Conditions
Biochemically Recurrent Prostate Cancer
Locations
  • Mayo Clinic Hospital - Phoenix - Cardiology Phoenix, Arizona, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Tower Urology Los Angeles, California, United States
View all 226 locations
View Trial Details